Menu Search
Equities

Thomson Medical Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
3H5:FRA

Thomson Medical Group Ltd

Actions
  • Price (EUR)0.038
  • Today's Change0.001 / 1.33%
  • Shares traded5.59k
  • 1 Year change+10.14%
  • Beta0.8056
Data delayed at least 15 minutes, as of Feb 16 2026 14:25 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Thomson Medical Group Limited is a Singapore-based company engaged in investments, investment holdings and strategic investments and other related activities. The Company’s subsidiaries are engaged in operating hospitals and clinics, and provision of healthcare services. Its segments include Singapore, Malaysia, Vietnam, and investment holdings. Through its subsidiary Thomson Medical Pte Ltd., it operates a network of approximately 37 specialist medical clinics and facilities, providing outpatient women and children healthcare services and service offerings in diagnostic imaging, health screening, gynecological oncology, dentistry, specialist dermatology, traditional Chinese medicine, musculoskeletal and sports medicine, and medical aesthetics. Its brands include Thomson Women's Clinic, Thomson Paediatric Clinic, Thomson Specialists, Thomson Fertility Centre, Thomson Dental Centre, Thomson Nutri, Thomson Baby, and others.

  • Revenue in SGD (TTM)408.67m
  • Net income in SGD-44.92m
  • Incorporated1999
  • Employees669.00
  • Location
    Thomson Medical Group Ltd101 Thomson Road#20-04/05 United Square 307591SingaporeSGP
  • Phone+65 63310188
  • Fax+65 63310180
  • Websitehttps://www.thomsonmedical.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.